In This Article:
Dividend-paying stocks are the gift that keeps on giving. They pay you a recurring stream of passive income that you can use to make new investments or cover some of your expenses. The best dividend stocks will send you more money each year by increasing their payments.
Anybody can gift oneself with a multiyear supply of passive income by purchasing shares of a high-quality dividend-paying company. Three great ones to consider buying are Coca-Cola (NYSE: KO), Johnson & Johnson (NYSE: JNJ), and NextEra Energy (NYSE: NEE).
A satisfying income stream
Coca-Cola has treated its investors like royalty over the years. The beverage giant has increased its dividend payment for 62 years in a row. That puts it in an elite group of dividend stocks. It qualifies as a Dividend King, a company with 50 or more years of consecutive annual dividend increases.
The company's dividend yield is currently over 3%. That's a lot higher than the average dividend stock, considering that the S&P 500 yields around 1.2% these days.
Coca-Cola should have plenty of pop to continue pushing its payout higher. The beverage company's long-term goal is to grow its revenue at a 4% to 6% organic rate each year, which should drive 7% to 9% annual earnings-per-share growth. The company's growing earnings and cash flow should enable it to continue increasing its dividend at a solid annual rate.
A very healthy dividend
Johnson & Johnson is a financial fortress. The healthcare giant has a higher credit rating than the U.S. government. It ended the last quarter with $20 billion of cash on its balance sheet, giving it only $16 billion of net debt, and that's after spending $18 billion on acquisitions over the past year. The healthcare company generated $14 billion in free cash flow through the third quarter, easily covering the $8.8 billion it paid in dividends.
The company's healthy financial profile has enabled it to steadily increase its dividend. Like Coca-Cola, Johnson & Johnson has delivered 62 years of annual dividend increases. Meanwhile, it offers a higher dividend yield that's approaching 3.5%.
Johnson & Johnson should be able to continue growing its dividend in the future. Those $18 billion in acquisitions over the past year should enhance its medical technology capabilities and pipeline of innovative medicines. The company has also invested nearly $12 billion in research and development. These investments should boost its revenue and earnings as it launches new products, which should allow it to continue increasing its dividend.